Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

Overview of attention for article published in BMC Cancer, March 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 1 X user

peer_reviews: 1 peer review site

Citations

dimensions_citation: 88 Dimensions

Readers on

mendeley: 117 Mendeley

Summary X Peer reviews Dimensions citations

So far, Altmetric has seen 1 X post from an account with 356 followers.

#newupdatesneuroonc #braintumours #neuroonc Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol. - https://t.co/A9CjvnFbIQ

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.